 UNIONDALE, N.Y., Dec. 21, 2022 GLOBE NEWSWIRE Angion Biomedica Corp NASDAQ:ANGN, a biopharmaceutical company that has focused on the discovery, development, and commercialization of novel small molecule therapeutics to address fibrotic diseases, announced that on December 15, 2022, it received a letter from the Nasdaq Listing Qualifications Staff of The Nasdaq Stock Market notifying ... The post Angion Receives Nasdaq Notice Regarding Minimum Bid Price Requirements appeared first on ForexT... 